
Alternatives to heparin anticoagulation for cardiopulmonary bypass and extracorporeal membrane oxygenation
Author(s) -
Sanjana A. Malviya,
Emily G Bruner,
Alexandra Belfar,
Yi Deng
Publication year - 2021
Publication title -
medical research archives
Language(s) - English
Resource type - Journals
eISSN - 2375-1924
pISSN - 2375-1916
DOI - 10.18103/mra.v9i8.2528
Subject(s) - extracorporeal membrane oxygenation , cardiopulmonary bypass , medicine , heparin , extracorporeal , extracorporeal circulation , circulatory system , coagulation , anesthesia , inflammatory response , intensive care medicine , thrombosis , oxygenation , surgery , cardiology , inflammation
Cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO) are both mechanical circulatory support technologies that augment the native heart and/or lung function. They involve drainage and reinfusion of blood while performing extracorporeal gas exchange. 1 In both devices, contact between patient blood and the non-endothelialized surface of the circuit triggers an inflammatory response and pro-coagulation cascade. 2–5 As a result, prophylactic anticoagulation is integral to prevent catastrophic thrombosis of the circuitry. In rare instances, there exist contraindications to heparin use, necessitating alternative management strategies. 6 In this review, we will examine heparin contraindications in mechanical circulatory support and summarize alternative approaches to anticoagulation in these circumstances.